SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001618835-22-000073
Filing Date
2022-03-24
Accepted
2022-03-24 16:03:08
Documents
16
Period of Report
2022-03-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evfm-20220324.htm   iXBRL 8-K 49909
2 EX-3.1 exhibit31-certificateofdes.htm EX-3.1 162051
3 EX-10.1 exhibit101-exchangeagreeme.htm EX-10.1 21142
8 GRAPHIC delawarestamp.jpg GRAPHIC 29873
  Complete submission text file 0001618835-22-000073.txt   502968

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20220324.xsd EX-101.SCH 2292
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evfm-20220324_def.xml EX-101.DEF 16917
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20220324_lab.xml EX-101.LAB 32731
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20220324_pre.xml EX-101.PRE 17713
10 EXTRACTED XBRL INSTANCE DOCUMENT evfm-20220324_htm.xml XML 14502
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 22766474
SIC: 2834 Pharmaceutical Preparations